Although a role for PRKACG and PRKAR1B in breast cancer has not been described, PRKACG has been shown to act as a RUNX1‐mutation associated hub gene in acute myeloid leukaemia29 and single nucleotide polymorphisms of PRKAR1B are associated with inferior survival of advanced renal cell cancer patients.30 The gene discussed is PRKACG; the disease is renal cell adenocarcinoma.